Logo image of UPH

UPHEALTH INC (UPH) Stock Fundamental Analysis

NYSE:UPH - New York Stock Exchange, Inc. - US91532B2007 - Common Stock - Currency: USD

0.3  +0.03 (+9.13%)

Fundamental Rating

1

UPH gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. UPH may be in some trouble as it scores bad on both profitability and health. UPH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year UPH has reported negative net income.
UPH had a negative operating cash flow in the past year.
UPH Yearly Net Income VS EBIT VS OCF VS FCFUPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -100M -200M -300M

1.2 Ratios

UPH's Return On Assets of -31.98% is in line compared to the rest of the industry. UPH outperforms 48.84% of its industry peers.
With a Return On Equity value of -117.29%, UPH is not doing good in the industry: 62.79% of the companies in the same industry are doing better.
UPH has a Return On Invested Capital of 1.59%. This is amongst the best in the industry. UPH outperforms 86.05% of its industry peers.
Industry RankSector Rank
ROA -31.98%
ROE -117.29%
ROIC 1.59%
ROA(3y)-42.12%
ROA(5y)N/A
ROE(3y)-106.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UPH Yearly ROA, ROE, ROICUPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -50 -100 -150 -200

1.3 Margins

With an excellent Operating Margin value of 0.90%, UPH belongs to the best of the industry, outperforming 81.40% of the companies in the same industry.
Looking at the Gross Margin, with a value of 45.52%, UPH is doing worse than 60.47% of the companies in the same industry.
Industry RankSector Rank
OM 0.9%
PM (TTM) N/A
GM 45.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
UPH Yearly Profit, Operating, Gross MarginsUPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -100 -200

More info and screens

1

2. Health

2.1 Basic Checks

UPH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for UPH has been increased compared to 1 year ago.
The debt/assets ratio for UPH is higher compared to a year ago.
UPH Yearly Shares OutstandingUPH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 5M 10M 15M 20M
UPH Yearly Total Debt VS Total AssetsUPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

UPH has an Altman-Z score of -3.70. This is a bad value and indicates that UPH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -3.70, UPH is not doing good in the industry: 67.44% of the companies in the same industry are doing better.
UPH has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of UPH (0.03) is better than 69.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -3.7
ROIC/WACC0.24
WACC6.53%
UPH Yearly LT Debt VS Equity VS FCFUPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.13 indicates that UPH may have some problems paying its short term obligations.
The Current ratio of UPH (0.13) is worse than 97.67% of its industry peers.
A Quick Ratio of 0.13 indicates that UPH may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.13, UPH is doing worse than 97.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
UPH Yearly Current Assets VS Current LiabilitesUPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

2

3. Growth

3.1 Past

UPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.97%, which is quite impressive.
Looking at the last year, UPH shows a small growth in Revenue. The Revenue has grown by 3.24% in the last year.
EPS 1Y (TTM)34.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.46%
Revenue 1Y (TTM)3.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.49%

3.2 Future

The Earnings Per Share is expected to grow by 23.89% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -0.68% on average over the next years.
EPS Next Y72.87%
EPS Next 2Y40.69%
EPS Next 3Y23.89%
EPS Next 5YN/A
Revenue Next Year-7.87%
Revenue Next 2Y-37.26%
Revenue Next 3Y-0.68%
Revenue Next 5YN/A

3.3 Evolution

UPH Yearly Revenue VS EstimatesUPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 50M 100M 150M
UPH Yearly EPS VS EstimatesUPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -5 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UPH. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UPH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UPH Price Earnings VS Forward Price EarningsUPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UPH is valued cheaply inside the industry as 90.70% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.37
UPH Per share dataUPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

UPH's earnings are expected to grow with 23.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.69%
EPS Next 3Y23.89%

More info and screens

0

5. Dividend

5.1 Amount

UPH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UPHEALTH INC

NYSE:UPH (12/11/2023, 8:20:46 PM)

0.3

+0.03 (+9.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-20 2023-11-20/amc
Earnings (Next)02-29 2024-02-29/amc
Inst Owners0.11%
Inst Owner Change0%
Ins Owners112.9%
Ins Owner Change0%
Market Cap5.33M
Analysts82.5
Price Target5.24 (1646.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-362.92%
Min EPS beat(2)-624.95%
Max EPS beat(2)-100.89%
EPS beat(4)1
Avg EPS beat(4)-206.44%
Min EPS beat(4)-624.95%
Max EPS beat(4)19.85%
EPS beat(8)3
Avg EPS beat(8)-213.41%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)14.44%
Min Revenue beat(2)13.83%
Max Revenue beat(2)15.05%
Revenue beat(4)4
Avg Revenue beat(4)11.19%
Min Revenue beat(4)0.81%
Max Revenue beat(4)15.06%
Revenue beat(8)4
Avg Revenue beat(8)2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.55%
PT rev (3m)-14.55%
EPS NQ rev (1m)43.5%
EPS NQ rev (3m)43.5%
EPS NY rev (1m)-11.26%
EPS NY rev (3m)-11.26%
Revenue NQ rev (1m)12.58%
Revenue NQ rev (3m)112482%
Revenue NY rev (1m)5.99%
Revenue NY rev (3m)5.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.08
P/tB N/A
EV/EBITDA 10.37
EPS(TTM)-7.7
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-1.31
OCFYN/A
SpS8.61
BVpS3.61
TBVpS-2.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.98%
ROE -117.29%
ROCE 2.01%
ROIC 1.59%
ROICexc 1.67%
ROICexgc N/A
OM 0.9%
PM (TTM) N/A
GM 45.52%
FCFM N/A
ROA(3y)-42.12%
ROA(5y)N/A
ROE(3y)-106.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.12
Cap/Depr 37.34%
Cap/Sales 3.21%
Interest Coverage 0.09
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z -3.7
F-Score5
WACC6.53%
ROIC/WACC0.24
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.46%
EPS Next Y72.87%
EPS Next 2Y40.69%
EPS Next 3Y23.89%
EPS Next 5YN/A
Revenue 1Y (TTM)3.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.49%
Revenue Next Year-7.87%
Revenue Next 2Y-37.26%
Revenue Next 3Y-0.68%
Revenue Next 5YN/A
EBIT growth 1Y102.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.28%
EBIT Next 3Y43.77%
EBIT Next 5YN/A
FCF growth 1Y45.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.9%
OCF growth 3YN/A
OCF growth 5YN/A